Page 2 - Morphosys Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys Development Today - Breaking & Trending Today

MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma


MorphoSys AG to Acquire Constellation Pharmaceuticals and Enter into Strategic Funding Partnership with Royalty Pharma
MUNICH, GERMANY and CAMBRIDGE, MA / ACCESSWIRE / June 2, 2021 / MorphoSys AG (FSE:MOR) (NASDAQ:MOR) ( MorphoSys ), announces today that it has entered into a definitive agreement with Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) ( Constellation ) whereby MorphoSys will acquire Constellation for $34.00 per share in cash, which represents a total equity value of $1.7 billion. The transaction has been unanimously approved by the Management Board (
Vorstand) and the Supervisory Board (
Aufsichtsrat) of MorphoSys, as well as the Board of Directors of Constellation and is expected to close in the third quarter of 2021. ....

United States , United Kingdom , Julia Neugebauer , Novarti Promacta , Myles Clouston , Merck Januvia , Development Funding Bonds , Janssen Biotech Inc , Morphosys Development Inc , Drug Administration , Constellation Pharmaceuticals Inc , Janssen Research Development , Morphosys Us Inc , Frankfurt Stock Exchange , Exchange Commission , Million Development Funding Bonds , Constellation Pharmaceuticals , Management Board , Supervisory Board , Royalty Pharma , Upfront Payment , Frankfurt Stock , Hart Scott Rodino Antitrust Improvements Act , Janssen Research , Janssen Biotech , Tender Offer Statement ,